Video

Dr. Tempero Discusses Hereditary Pancreatic Cancer

Margaret A. Tempero, MD, director, Pancreas Center, University of California, San Francisco, discusses the two main types of hereditary pancreatic cancer.

Margaret A. Tempero, MD, director, Pancreas Center, University of California, San Francisco, discusses the two main types of hereditary pancreatic cancer.

Some types of hereditary pancreatic cancer can be defined by a genetic alteration, such as the BRCA mutation syndromes or hereditary nonpolyposis colorectal cancer syndromes. However, there are also patients that do not have a known genetic determinant but yet pancreatic cancer still seems to run in the family.

If an individual has one affected first-degree relative, their risk goes up, Tempero says. The risk continues to increase as the number of first-degree relatives diagnosed with pancreatic cancer increases. Tempero says there are a number of these families that are being followed. It is likely, Tempero says, that each family has a different genetic reason for getting this cancer. Therefore, there is not a common genetic mutation and each family needs to be investigated separately.

<<<

View more from the 2014 World GI Congress

Related Videos
Albert Grinshpun, MD, MSc, head, Breast Oncology Service, Shaare Zedek Medical Center
Erica L. Mayer, MD, MPH, director, clinical research, Dana-Farber Cancer Institute; associate professor, medicine, Harvard Medical School
Stephanie Graff, MD, and Chandler Park, FACP
Mariya Rozenblit, MD, assistant professor, medicine (medical oncology), Yale School of Medicine
Maxwell Lloyd, MD, clinical fellow, medicine, Department of Medicine, Beth Israel Deaconess Medical Center
Neil Iyengar, MD, and Chandler Park, MD, FACP
Azka Ali, MD, medical oncologist, Cleveland Clinic Taussig Cancer Institute
Rena Callahan, MD, and Chandler Park, MD, FACP
Hope S. Rugo, MD, FASCO, Winterhof Family Endowed Professor in Breast Cancer, professor, Department of Medicine (Hematology/Oncology), director, Breast Oncology and Clinical Trials Education; medical director, Cancer Infusion Services; the University of California San Francisco Helen Diller Family Comprehensive Cancer Center
Virginia Kaklamani, MD, DSc, professor, medicine, Division of Hematology-Medical Oncology, The University of Texas (UT) Health Science Center San Antonio; leader, breast cancer program, Mays Cancer Center, UT Health San Antonio MD Anderson Cancer Center